{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T04:30:25Z","timestamp":1778819425865,"version":"3.51.4"},"reference-count":15,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2009,8]]},"DOI":"10.1097\/jcp.0b013e3181accfd9","type":"journal-article","created":{"date-parts":[[2009,7,3]],"date-time":"2009-07-03T07:27:35Z","timestamp":1246606055000},"page":"396-398","source":"Crossref","is-referenced-by-count":18,"title":["The Effects of Risperidone on the Cognitive Performance of Individuals With Schizotypal Personality Disorder"],"prefix":"10.1097","volume":"29","author":[{"given":"Margaret M.","family":"McClure","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Harold W.","family":"Koenigsberg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Diedre","family":"Reynolds","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marianne","family":"Goodman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antonia","family":"New","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert","family":"Trestman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jeremy","family":"Silverman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Philip D.","family":"Harvey","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Larry J.","family":"Siever","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"issue":"2","key":"R1-20-20210128","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1080\/13803390500360372","article-title":"Premorbid intellectual functioning and risk of schizophrenia and spectrum disorders.","volume":"28","author":"Reichenberg","year":"2006","journal-title":"J Clin Exp Neuropsychol"},{"issue":"3","key":"R2-20-20210128","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1037\/0003-066X.60.3.229","article-title":"The primacy of cognition in schizophrenia.","volume":"60","author":"Heinrichs","year":"2005","journal-title":"Am Psychol"},{"issue":"3","key":"R3-20-20210128","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1176\/appi.ajp.162.3.495","article-title":"Predictive values of neurocognition and negative symptoms on functional outcome in schizophrenia: a longitudinal first-episode study with 7-year follow-up.","volume":"162","author":"Milev","year":"2005","journal-title":"Am J Psychiatry"},{"issue":"6","key":"R4-20-20210128","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1176\/appi.ajp.159.6.1018","article-title":"Neurocognitive effects of clozapine, olanzapine, risperidone, and haloperidol in patients with chronic schizophrenia or schizoaffective disorder.","volume":"159","author":"Bilder","year":"2002","journal-title":"Am J Psychiatry"},{"issue":"6","key":"R6-20-20210128","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1097\/00131746-200511000-00003","article-title":"Strategies for improving adherence to second-generation antipsychotics in patients with schizophrenia by increasing ease of use.","volume":"11","author":"Burton","year":"2005","journal-title":"J Psychiatr Prac"},{"key":"R7-20-20210128","doi-asserted-by":"crossref","first-page":"1986","DOI":"10.1176\/appi.ajp.162.10.1896","article-title":"Neuropsychological performance in schizotypal personality disorder: importance of working memory.","volume":"162","author":"Mitropoulou","year":"2005","journal-title":"Am J Psychiatry"},{"key":"R8-20-20210128","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/S0920-9964(99)00085-7","article-title":"Visuospatial working memory in schizotypal personality disorder patients.","volume":"41","author":"Roitman","year":"2000","journal-title":"Schizophr Res"},{"key":"R9-20-20210128","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1093\/schbul\/22.3.501","article-title":"The factor structure of schizotypal symptoms in a clinical population.","volume":"22","author":"Bergman","year":"1996","journal-title":"Schizophr Bull"},{"key":"R10-20-20210128","first-page":"655","article-title":"Attentional functioning in schizotypal personality disorder.","volume":"154","author":"Roitman","year":"1997","journal-title":"Am J Psychiatry"},{"key":"R11-20-20210128","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1016\/j.biopsych.2006.06.034","article-title":"The effects of guanfacine on context processing abnormalities in schizotypal personality disorder.","volume":"61","author":"McClure","year":"2007","journal-title":"Biol Psychiatry"},{"key":"R12-20-20210128","doi-asserted-by":"crossref","first-page":"628","DOI":"10.4088\/JCP.v64n0602","article-title":"Risperidone in the treatment of schizotypal personality disorder.","volume":"64","author":"Koenigsberg","year":"2003","journal-title":"J Clin Psychiatry"},{"issue":"3","key":"R13-20-20210128","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1017\/S146114570500516X","article-title":"A meta-analysis of cognitive change to clozapine, olanzapine, quetiapine, and risperidone in schizophrenia.","volume":"8","author":"Woodward","year":"2005","journal-title":"Int J Neuropsychopharmacology"},{"key":"R14-20-20210128","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1176\/appi.ajp.158.2.176","article-title":"Studies of cognitive change in patients with schizophrenia following novel antipsychotic treatment.","volume":"158","author":"Harvey","year":"2001","journal-title":"Am J Psychiatry"},{"key":"R15-20-20210128","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1016\/S0893-133X(01)00249-4","article-title":"Guanfacine treatment of cognitive impairment in schizophrenia.","volume":"25","author":"Friedman","year":"2001","journal-title":"Neuropsychopharmacology"},{"key":"R16-20-20210128","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1001\/archpsyc.64.6.633","article-title":"Neurocognitive effects of antipsychotic medications in patients with chronic schizophrenia in the CATIE Trial.","volume":"64","author":"Keefe","year":"2007","journal-title":"Arch Gen Psychiatry"}],"container-title":["Journal of Clinical Psychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/journals.lww.com\/00004714-200908000-00020","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,4,10]],"date-time":"2021-04-10T06:14:31Z","timestamp":1618035271000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00004714-200908000-00020"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,8]]},"references-count":15,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2009]]}},"URL":"https:\/\/doi.org\/10.1097\/jcp.0b013e3181accfd9","relation":{},"ISSN":["0271-0749"],"issn-type":[{"value":"0271-0749","type":"print"}],"subject":[],"published":{"date-parts":[[2009,8]]}}}